Benicar (olmesartan), a new angiotensin receptor blocker for hypertension
May 2002
Reps will soon be promoting Benicar (olmesartan), a new angiotensin receptor blocker for hypertension.
It will be the seventh one on the market...after Cozaar (losartan), Diovan (valsartan), Avapro (irbesartan), Atacand (candesartan), Micardis (telmisartan), and Teveten (eprosartan).
Reps might tell you that Benicar is more effective...but don't get too excited. It's pretty much a "me-too."
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote